News | January 18, 2023
Glenmark to divest select dermatology brands for Rs. 340.48 Cr
The divested brands include Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands
The divested brands include Onabet, Halovate, Sorvate, Luligee, Demelan, Aceret, Dosetil, Revize, and Powercort, and their sub-brands
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
Monika and Prathmesh’s determination to participate in the Dream Run to increase awareness serves as a testament to life changing effects of organ transplants and importance of organ donation
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Collaboration to generate and develop therapeutics for oncology and non-oncology conditions
The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services
Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Subscribe To Our Newsletter & Stay Updated
